Earth kinase enteric capsules have no significant effect on interstitial vein thrombosis. Earth kinase is a group of protein hydrolases containing fibrinolytic enzymes and fibrin bathogen activators. Earth kinase enteric capsule is mainly suitable for platelet aggregation rate increased, or ischemic cerebrovascular disease patients with increased fibrinogen; this drug is mainly used for anti-platelet aggregation, prevent the occurrence of thrombus, so for the already formed thrombus has no obvious therapeutic effect. Earth kinase enteric-coated capsule may cause constipation, dizziness, mild headache, nausea and other symptoms; this drug should be taken before meals, and for patients with bleeding tendency, it should be used under the guidance of a doctor. The drug may also cause allergic reactions, so patients who are allergic to this drug should avoid taking it. After the occurrence of thrombosis, patients should go to the hospital in time to improve the examination, clear diagnosis and follow the doctor’s instructions for treatment.